Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia

Hum Genomics. 2024 Dec 18;18(1):137. doi: 10.1186/s40246-024-00706-5.

Authors

Vita Andreja Mesarič^{1

2}, Ana Blatnik^{2

3}, Kristina Drusany Starič^{1

2}, Ksenija Strojnik³, Vida Stegel^{2

3}, Simona Hotujec³, Vita Šetrajčič Dragoš^{2

3}, Petra Škerl³, Srdjan Novaković^{2

3}, Mateja Krajc^{4

5}

Affiliations

¹ Ljubljana University Medical Centre, Ljubljana, Slovenia.
² University of Ljubljana, Ljubljana, Slovenia.
³ Institute of Oncology Ljubljana, Ljubljana, Slovenia.
⁴ University of Ljubljana, Ljubljana, Slovenia. mkrajc@onko-i.si.
⁵ Institute of Oncology Ljubljana, Ljubljana, Slovenia. mkrajc@onko-i.si.

No abstract available

Grants and funding